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ABSTRAK
Tujuan: mengetahui kesintasan jangka pendek dalam 28 hari pada pasien acute respiratory distress syndrome 
(ARDS). Metode: studi retrospektif dilakukan di rumah sakit pusat rujukan tersier di Jakarta, Indonesia. Pada 
studi ini, digunakan data rekam medis yang diambil selama 10 bulan, yaitu Oktober 2015 hingga Agustus 2016. 
Keluaran primer studi ini adalah kesintasan jangka pendek selama 28 hari terhitung sejak pasien didiagnosis 
sebagai ARDS. Hasil yang didapatkan kemudian dianalisis menggunakan Kaplan-Meier dan analisis multivariat 
Cox regresi. Hasil: studi ini mendapatkan 101 pasien ARDS dalam periode 10 bulan. Kesintasan keseluruhan 
selama 28 hari adalah 47.5% dan nilai median adalah 10 hari (95% CI 2.47 – 17.52). Kesintasan pada pasien 
ARDS cenderung menurun signifikan pada minggu pertama setelah didiagnosis ARDS. Hal itu menunjukkan 
mortalitas tertinggi terjadi pada minggu pertama. Skor APACHE II >20 menunjukkan HR 2.45 (95% CI 1.40-
4.28) dan derajat ARDS moderat-berat menunjukkan HR 2.27 (95% CI 1.25-4.12). Kesimpulan: kesintasan 
jangka pendek di negara berkembang seperti Indonesia masih rendah dan manajemen yang optimal pada awal 
dari minggu pertama pada pasien ARDS akan memperbaiki tingkat kesintasan.
Kata kunci: sindrom distres pernapasan akut, kesintasan, negara berkembang
ABSTRACT
Aim: to identify the 28-day short-term survival rate in patients with acute respiratory distress syndrome 
(ARDS). Methods: this is a retrospective cohort study conducted at a tertiary referral hospital in Jakarta, Indonesia. 
We conducted the study for 10 months and data was extracted from medical records between October 2015 and 
August 2016. The primary end point of the study was 28-day short-term survival rate using the initial date of ARDS 
diagnosis as the index time. Overall survival rate was analyzed using Kaplan-Meier test and multivariate Cox 
regression analysis. Results: there were 101 ARDS subjects during 10 months of study. The overall rate of  28-day 
survival was 47.5% and the median time of survival was 10 days (95% CI 2.47–17.52). The survival rate in ARDS 
patients was reduced significantly at the first week after the diagnosis of ARDS was made, which indicated that the 
highest mortality occured in the first week. Subjects with APACHE II score of >20 had a hazard ratio (HR) of 2.45 
(95% CI 1.40-4.28) and those with moderate-severe of ARDS had HR of 2.27 (95% CI 1.25-4.12). Conclusion: the 
short-term survival rate of ARDS in developing countries  including Indonesia is still low and early management 
with optimal treatment provided within the first week may improve the survival rate.
Keywords: ARDS, survival, developing countries.
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INTRODUCTION
Acute respiratory distress syndrome (ARDS) 
is an intense inflammation of lung that may 
lead to life-threatening condition. Patients are 
usually treated with supportive ventilation.1-3 
ARDS has been well studied by many developed 
countries,4-6 and mortality has been reduced 
to up to 30%. Nevertherless, the survival rate 
remains moderate to low in developing countries 
including Indonesia. It may be due to some major 
problems such as limited access to hospitals, 
lack of facilities and ARDS is under-diagnosed 
by most clinicians.
Early identification based on the knowledge 
of short-term survival rate of ARDS may help 
clinicans in acute care setting to predict earlier 
prognosis and provide help for appropriate and 
prompt treatment. Clinicians should be more 
aware about the best time to provide supportive 
care or perform careful observation for ARDS 
patients, particularly the underdiagnosed case. 
Our data is limited on this issue.7 Therefore, 
the burden of ARDS remains underreported in 
Indonesia.
Moreover, most published studies in Asian 
developing countries still use the old criteria 
of AECC (American-European Consensus 
Conference) definition, which would now be 
obsolete. To our knowledge, our study is the 
first study using new criteria of Berlin definition 
in Indonesia. We hope that our study could be 
a trigger to improve the management of ARDS 
and may provide an insight about the burden 
of ARDS and consequently; therefore, any 
deterioration can be prevented earlier.
METHODS
Study Design and Population
A retrospective cohort study was conducted 
at Cipto Mangunkusumo General Hospital, a 
national referral hospital in Jakarta, Indonesia. 
We enrolled all adult patients aged 18 years and 
older who were admitted to the hospital with 
a diagnosis of ARDS as documented on their 
medical records. The study was conducted in 10 
months, i.e. between October 2015 and August 
2016.
Diagnosis of ARDS was defined using the 
criteria of Berlin definition. The definition of 
ARDS in Berlin criteria was characterized 
by the following key components: there was 
acute onset over 1 week or less following any 
identified clinical event; de novo respiratory 
symptoms or worsening of previous respiratory 
symptoms; bilateral opacities detected on chest 
X-ray or CT, which may not be fully explained 
by  pleural effusions; respiratory failure, which 
must not be fully explained by cardiac failure 
or fluid overload. The ARDS was categorized 
as being mild (200 mmHg <PaO2/FiO2 ≤300 
mmHg with PEEP ≥5 cmH2O), moderate (100 
mmHg <PaO2/FiO2 ≤200 mmHg with PEEP ≥5 
cmH2O), and severe (PaO2/FiO2 ≤100 mmHg 
with PEEP ≥5 cmH2O).8
Primary and Secondary Endpoints
The primary endpoint of our study was the 
28-day short-term survival rate using the initial 
date of hospital admission as the index time. 
Secondary endpoint included factors (APACHE 
II score, severity) that might affect the survival. 
Those variables were classified as dichotomous 
variables. Our study has been approved by Ethic 
Committe of Faculty of Medicine University of 
Indonesia, registration number: 998/UN2.F1/
ETIK/2015. Informed consent to the sujects was 
not requested since our study was observational 
and we followed the routine practice in our 
setting.
Sample Size
Short-term survival rate as the primary end 
point of our study was used to calculate sample 
size. We used the survival rate obtained from a 
previous large-scale study conducted by Bellani 
G, et al6 as a baseline. The study included 50 
countries over 5 continents and the 28-day 
survival rate showed by that study was 60.4%.6 
The confidence level was set at 95% and the 
precision of predicted survival rate was set at 15% 
in 28 days since there might be different survival 
rate between developed and developing countries. 
The minimum sample size, which should be 
obtained in our study was 91 patients. A 10% drop-
out rate was anticipated; thus, a minimum sample 
size of 101 subjects was determined.
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Statistical Analysis
We used SPSS 20.0 (Chicago, USA) to 
analyse the data. Dichotomous variables were 
presented as number or percentage. The overall 
survival was analyzed using Kaplan Meier test 
and the date of first hospital admission day was 
determined as the index date.  We presented the 
result of overall survival rate in percentage, the 
median time of survival  in days and the specific 
time when most patients had  faster deterioration. 
We also performed mulivariate Cox regression 
analysis to examine survival time with variables 
included in the model and the results were 
reported with their corresponding hazard ratio 
and 95% CI. We considered p-value of less than 
0.05 as significantly different.
RESULTS
There were 101 subjects participated in our 
study. Important clinical characteristics related 
to ARDS were shown Table 1. Mean age was 
52.7±17.2 years. Out of 101 subjects, 45 (45.5%) 
subjects aged less than 60 years and 55 (54.4%) 
subjects aged over 60 years. There was a slight 
male dominance. Approximately 83% patients 
had ARDS risk factors such as extrapulmonary 
sepsis and pneumonia. As many as 63.4% 
patients had APACHE II score of less than 20 
and the rest had score of more than 20.
Survival Rate
The overall 28-day survival was 47.5% and 
median time of survival was 10 days (95% CI 
2.47–17.52). The survival rate was more likely 
to have a significant drop in the first week 
compared to the following weeks. Almost 50% 
patients died in the first week. It indicated that 
the highest mortality in ARDS patients occured 
in the first week.
The survival of ARDS patient with mild, 
moderate, and severe grade were 63.6%, 38.9%, 
and 28.6%, respectively. The median of survival 
time for mild, moderate and severe were 21, 5, 
and 3 days. 
Table 1. Main characteristics of patients with ARDS
Parameters n (%) Survivors, n (%) Non-survivors, n (%)
Age 
 - ≥60 years old 55 (54.4) 25 (45.4) 30 (55.6)
 - <60 years old 46 (45.6) 23 (50) 23 (50)
Gender
 - Male 48 (47.5) 26 (54.2) 22 (45.8)
 - Female 53 (52.5) 22 (41.5) 31 (58.5)
APACHE II 
 - <20 66 (65.3) 37 (56.1) 29 (43.9)
 - >20 35 (34.7) 11 (31.4) 24 (68.6)
Severity
 - Mild 44 (43.5) 28 (63.6) 16 (36.4)
 - Moderate 36 (35.7) 14 (38.9) 22 (61.1)
 - Severe 21 (20.8) 6 (28.6) 15 (71.4)
Gas exchange, first day of 
ARDS
 - PaO2/FiO2 ratio [(median 
min-max)], mmHg
221 (41-612) 142 (53-624)
 - PaCO2 [(median  min-
max)], mmHg
31.4 (17.3-77.10) 32.6 (1-73)
 - pH [(median  min-max)] 7.43 (7.14-7.61) 7.43(7.03-7.61)
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DISCUSSION
The survival rate of ARDS patients remains 
low and varies widely. Most studies have 
reported that the mortality rate ranges from 30 to 
60%.9,24 The overall survival of ARDS patients 
Table 2. Cox regression analysis of ARDS patients
Variables Hazard ratio 95% CI p-value
APACHE II 2.45 1.40-4.28 .002
Severity 2.27 1.25-4.12 .007
mild vs moderate-
severe
Figure 1. The overall 28-day survival rate since the first 
diagnosis of  ARDS.
Figure 2. Kaplan-Meier survival analysis of 28-day survival 
rate according to severity of ARDS. The survival was lower 
for those with moderate-severe ARDS compared to those 
with mild ARDS (p = 0.004, log-rank test).
in the lung-protective ventilation era has shown 
an increasing trend.
A recent large-scale study conducted by 
Bellani et al,6 which was performed  in 50 
countries across 5 continents, showed that the 
survival rate has reached 60.4% (95% CI 58,7-
62,2). Mansur A et al10 showed that the 28-day 
survival rate among ARDS caucasian patients is 
over 65%; furthermore, the survival rate in mild-
moderate grade patients is even higher, which is 
more than 85%.
However, there are limited studies conducted 
in Asia on survival of ARDS, especially in 
developing countries. A previous small-sized 
study conducted in a single tertiary care center 
in Pakistan showed that the 28-day of survival 
rate is 44%.11 A large retrospective study in 
Taiwan between 1997 and 2011 showed that the 
overall in-hospital mortality rate was 57.8% and 
the rate was decreased from 59.7% to 47.5% in 
2011 (p<0.001).12 In our study, the survival rate 
is similar to most studies conducted in Asia, 
especially in lower-middle-income countries. 
(Table 3)
Compared to the mortality rate of ARDS 
patients in a high- or upper-middle-income 
countries such Singapore, China and Japan, 
the mortality rate is higher in the lower-middle 
income countries.13 A study conducted by Lew 
T et al in Singapore showed that mortality at 28 
days for their entire cohort was 10.1% and for 
ICU death, the rate was 37%. A Japanese study 
by Endo S et al showed that the 30-day mortality 
rate of acute lung injury (ALI) and ARDS were 
21.6% and 20.5%, respectively.14 Moreover, the 
hospital mortality rate in Iceland decreased by 
1% per year, i.e. from 50% in 1988-1992 to 33% 
in 2006-2010.15 ARDS mortality rate is still high 
in many developing countries where the facilities 
for intensive care and assisted ventilation are 
not widely available. There is a need to provide 
intensive care that is accessible and affordable 
to patients.
A study conducted in Singapore by Lew et 
al13 also showed that the in-hospital mortality 
rate is the lowest (33.5%) in young patients 
(age 18-29 years) and the highest (68.2%) in the 
elderly patients (>80 years, p<0.001). Patients 
who died during hospitalization are older and 
Zulkifli Amin                                                                                                                            Acta Med Indones-Indones J Intern Med
304
predominantly male. Moreover, there is a lower 
mortality rate of ARDS patients at younger age 
(36%) as shown by a study conducted in India.16 
In our study, almost 50% of our patients are <60 
years old and the mortality rate is similar between 
young and elderly patients. Some studies have 
shown that the age distribution of ARDS patients 
are variable. A small sample study in a rural 
area of India shows that the mortality among 
ARDS patients are 36.4% and it is possibly due 
to different baseline characteristics compared 
to other studies as the study included younger 
age of subjects and tropical disease.16 However, 
several Asian studies have demonstrated that 
most subjects are at younger age and elderly age 
is usually associated with the increased risk of 
death.11,12,14,16,17
As we have known, the mortality rate in 
patients with ARDS is similar for both  genders, 
either male or female, and many studies 
have reported various results.12,18,19 Further 
investigations should be conducted by assesing 
the sex hormone level or sex-specific gene 
polymorphism in Asian races related to ARDS 
risk.
Mortality rate is found to be higher with 
greater ARDS severity.6,10 The Berlin definition 
has a better classification to predict mortality 
compared to the old definition of AECC. 
Major studies  including our findings have 
been consistent with the Berlin classification. 
Moreover, lower APACHE II scores and 
higher baseline ratio of PaO
2
 to fraction of 
inspired oxygen are associated with earlier 
recovery.11,13,15,16 Our findings are also consistent 
with the results of previous studies. APACHE 
II score still can serve as the ‘gold standar’ to 
predict the deterioration in ARDS. However, 
many parameters should be included in the score 
and applying the score every 24-48 hours is not 
practical to many settings in the middle-income 
countries. A new score with fewer parameters, 
but having similar capacity as APACHE II score 
is urgently needed, especially in our country.
Many studies have also shown that the 
highest mortality among ARDS patients is found 
within the first week after the diagnosis of ARDS 
is made.10,16,20 However, a study conducted in 
Singapore reveals that the highest mortality 
among SARS-associated ARDS patients is found 
after the patients spending 7 days in ICU due to 
late complications.11
Different etiologies of ARDS may affect the 
survival rate found in those studies. Classifying 
the etiologies would be useful to provide 
information whether a certain etiology can 
contribute to a higher risk of ARDS deterioration. 
Some measures may prevent the development 
of ARDS including prompt resuscitation within 
6 hours, early administration of effective 
antimicrobials and appropriate control of source 
of infection.21
Optimal management and careful observation 
in ARDS patients within the first week of 
their hospitalization would prevent further 
deterioration and ultimately, it can decrease the 
Table 3. Comparison the mortality/survival rate of ARDS from various studies among developing countries in Asia
Studies Countries Mortality/survival rate Criteria
Hartini, et al7 Indonesia
Study in a tertiary care hospital, the overall mortality rate of 
mechanically ventilated patients was 65.7%.
AECC
Sharif N, et al11 Pakistan
Study in a single tertiary care center, the 28-day  survival rate was 
44%.
AECC
George T, et al16 India
Study in a rural-urban hospital, the overall mortality rate was 
36.6%. Patients were dominated with younger age and tropical 
infection.
AECC
Varghese GM, et al22 India
Study in a university teaching hospital, the overall mortality rate of 
ARDS patients with scrub typhus was 67.9% 
Not mentioned
Bhadade RR, et al23 India
Study in a tertiary care hospital, the overall mortality was 57%. 
Patients were dominated with younger age and tropical infection.
AECC
Singh G, et al24 India
Study in a tertiary care hospital, the overall  mortality in those with 
ARDS admitted to surgical intensive care unit was 41.8%. 
AECC
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mortality rate and complications. A previous 
study conducted by Sharif N et al showed that 
high APACHE II score, sepsis, multiorgan failure, 
refractory shock, and refractory hypoxemia are 
the leading causes of death in ARDS patients.11 
Results of our study are consistent with their 
findings regarding the fact that the APACHE 
II score did affect the mortality rate and in our 
study, our subjects were also predominated by 
sepsis and pneumonia.
We admit that there are some limitations of 
our study since it was a retrospective design with 
a single center setting.
Nevertheless, our focus is on the overall 
survival rate among ARDS patients found in our 
setting and our study is  the first study reporting 
the actual condition in Indonesia. Further studies 
are required and preferably to be performed in 
multicenter settings with a higher power of study. 
Classifying ARDS based on the specific etiology 
and conducting a large-scale epidemiological 
study may be beneficial to raise the awareness of 
this devastating clinical syndrome in developing 
world.
CONCLUSION
Our study demonstrates that the short-term 
survival rate of ARDS is 47.5%. There is equal 
distribution of age, gender and sepsis among 
survivors and non survivors. High APACHE II 
score and severe grade are associated with high 
mortality. Earlier optimal management provided 
in the first week may increase the survival rate 
of ARDS patiens.
The overall survival rate of ARDS patients 
in the era of lung-protective ventilation has been 
improved over time either in high- or low-middle 
income countries. However, lower survival rate is 
found in lower-middle income countries. It may 
be related to disparity in facilities and resource, 
which causes the identification of ARDS cases 
and management of ARDS treatment to less 
optimal than high-income countries since in 
those countries,  ARDS guideline have been 
routinely applied.
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